Nalaganje...
IMMU-39. FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTI-TUMOR EFFICACY
Immunotherapies using engineered T lymphocytes expressing chimeric antigen receptors (CAR-T cells) are showing great promise against glioblastoma but are still limited by the escape of antigen-deficient clones and by inefficient latching of the T cells to target cells surrounded by extracellular mat...
Shranjeno v:
| izdano v: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216372/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.542 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|